Section III 
model that under different parameters, which might include things that are 
now not dealt with in the FTC protocol, such as the blocking of ventilation 
holes that are used to dilute the smoke in some brands that now list as being 
low yield, but in fact can become high yield when a human finger or a 
human lip blocks those vents. 
PARTICIPANT: Can you tell us what the role of other Federal agencies is 
going to be? 
DR. FREEMAN: 1 am not an expert on the bureaucracy of America. However, 
we did get somewhat of a description of the FTC role in our meeting here 
today, which is a role that I understand deals with truth in advertising as 
one of its major roles. And to make a personal statement here, I think that 
is a limited role with respect to what we are trying to accomplish for the 
American public. 
We found out today that 40 percent of cigarettes smoked in America are 
generics, and these for the most part are not advertised. However, the FTC 
in most of its role is limited to making statements about cigarettes that are 
advertised. So that if nearly half the cigarettes smoked in America are not 
advertised, it diminishes the FTC's role. Yet, the American public needs to 
know about the lethal nature of all cigarettes. 
Now, as far as the FDA is concerned, again, I am not an expert on what 
they do, but I think their role is different from the FTC and may get more 
into the range of health concerns, hopefully. So, I cannot give you a finite 
answer. Perhaps my colleagues can help me out. 
DR. SHIFFMAN: I would just add that the current FTC system operates 
under a voluntary agreement with the tobacco industry and cigarette 
manufacturers, and the representatives of that industry who addressed us 
during this meeting expressed an interest on the part of the industry of 
keeping consumers and smokers informed. We expect that they would 
follow through on that then in taking this step to make sure that accurate, 
useful information is available to smokers. 
PARTICIPANT: Is it your understanding that if the regulatory agencies 
wanted to do this, that legislation would be necessary? 
DR. FREEMAN: To do exactly what? 
PARTICIPANT: To carry out your recommendations? 
DR. FREEMAN: It is our belief that most of what we have recommended 
could be carried out by the FTC without congressional change. Our worry 
is that 40 percent of cigarettes are not regulated in a similar manner. Our 
concern is about the health of the American public and that the bureaucracy 
that we must go through to accomplish some of these things sometimes 
is a barrier to that. The FTC has regulations; the FDA has regulations, but 
sometimes what must be done or what should be done to save lives is 
beyond the confines of a certain agency, and this is somewhat of a problem. 
245 
